Acta Neuropathologica

, Volume 120, Issue 6, pp 827–828 | Cite as

Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment

  • Charles H. Adler
  • John N. Caviness
  • Marwan N. Sabbagh
  • Holly A. Shill
  • Donald J. Connor
  • Lucia Sue
  • Virgilio G. H. Evidente
  • Erika Driver-Dunckley
  • Thomas G. Beach
Correspondence

References

  1. 1.
    Aarsland D, Perry R, Brown A, Larsen JP, Ballard C (2005) Neuropathology of dementia in Parkinson’s disease: a prospective, community-based study. Ann Neurol 58:773–776CrossRefPubMedGoogle Scholar
  2. 2.
    Adler CH, Hentz JG, Joyce JN, Beach T, Caviness JN (2002) Motor impairment in normal aging, clinically possible Parkinson’s disease, and clinically probable Parkinson’s disease: longitudinal evaluation of a cohort of prospective brain donors. Parkinsonism Relat Disord 9:103–110CrossRefPubMedGoogle Scholar
  3. 3.
    Beach TG, Adler CH, Lue L et al (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613–634CrossRefPubMedGoogle Scholar
  4. 4.
    Beach TG, Sue LI, Walker DG et al (2008) The Sun Health Research Institute Brain Donation Program: description and experience, 1987–2007. Cell Tissue Bank 9:229–245CrossRefPubMedGoogle Scholar
  5. 5.
    Caviness JN, Driver-Dunckley E, Connor DJ et al (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22:1272–1277CrossRefPubMedGoogle Scholar
  6. 6.
    Choi SA, Evidente VG, Caviness JN et al (2010) Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia? Acta Neuropathol 119:147–149CrossRefPubMedGoogle Scholar
  7. 7.
    Hurtig HI, Trojanowski JQ, Galvin J et al (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease. Neurology 54:1916–1921PubMedGoogle Scholar
  8. 8.
    Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord 21:1343–1349CrossRefPubMedGoogle Scholar
  9. 9.
    Jellinger KA (2006) Pathological substrate of dementia in Parkinson’s disease–its relation to DLB and DLBD. Parkinsonism Relat Disord 12:119–120CrossRefPubMedGoogle Scholar
  10. 10.
    Sabbagh MN, Adler CH, Lahti TJ et al (2009) Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord 23:295–297CrossRefPubMedGoogle Scholar
  11. 11.
    Sabbagh MN, Shah F, Reid RT et al (2006) Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging. Arch Neurol 63:1771–1776CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Charles H. Adler
    • 1
  • John N. Caviness
    • 1
  • Marwan N. Sabbagh
    • 2
  • Holly A. Shill
    • 2
  • Donald J. Connor
    • 2
  • Lucia Sue
    • 3
  • Virgilio G. H. Evidente
    • 1
  • Erika Driver-Dunckley
    • 1
  • Thomas G. Beach
    • 3
  1. 1.Department of NeurologyMayo Clinic ArizonaScottsdaleUSA
  2. 2.Cleo Roberts Center for Clinical ResearchBanner Sun Health Research InstituteSun CityUSA
  3. 3.Civin Laboratory for NeuropathologyBanner Sun Health Research InstituteSun CityUSA

Personalised recommendations